Fresenius Kabi Deutschland GmbH — China drug registrations and re-registration deadlines
18 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2028-12-10.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20240040 | Linezolid and Glucose Injection 利奈唑胺葡萄糖注射液 | 2029-06-10 | 2028-12-10 |
| 国药准字HJ20150654 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20150655 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20150656 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20150657 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20150658 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20150659 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20150660 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20150661 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20150662 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20150663 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20160360 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20160671 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20171120 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20181145 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20181223 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20191011 | Propofol Medium and Long Chain Fat Emulsion Injection 丙泊酚中/长链脂肪乳注射液 | 2030-03-31 | 2029-09-30 |
| 国药准字HJ20210060 | Multi-trace Elements Injection (III) 多种微量元素注射液（Ⅲ） | 2031-03-01 | 2030-09-01 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.